ID: ALA5191894

Max Phase: Preclinical

Molecular Formula: C20H26FN3O

Molecular Weight: 343.45

Associated Items:

Representations

Canonical SMILES:  CCCCCCC(=O)Nc1ccc(NCc2ccccc2F)cc1N

Standard InChI:  InChI=1S/C20H26FN3O/c1-2-3-4-5-10-20(25)24-19-12-11-16(13-18(19)22)23-14-15-8-6-7-9-17(15)21/h6-9,11-13,23H,2-5,10,14,22H2,1H3,(H,24,25)

Standard InChI Key:  UQFSJQFLFGXJCN-UHFFFAOYSA-N

Associated Targets(Human)

Voltage-gated potassium channel, KQT; KCNQ2(Kv7.2)/KCNQ3(Kv7.3) 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.45Molecular Weight (Monoisotopic): 343.2060AlogP: 4.93#Rotatable Bonds: 9
Polar Surface Area: 67.15Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.16CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.45Np Likeness Score: -1.42

References

1. Musella S, Carotenuto L, Iraci N, Baroli G, Ciaglia T, Nappi P, Basilicata MG, Salviati E, Barrese V, Vestuto V, Pignataro G, Pepe G, Sommella E, Di Sarno V, Manfra M, Campiglia P, Gomez-Monterrey I, Bertamino A, Taglialatela M, Ostacolo C, Miceli F..  (2022)  Beyond Retigabine: Design, Synthesis, and Pharmacological Characterization of a Potent and Chemically Stable Neuronal Kv7 Channel Activator with Anticonvulsant Activity.,  65  (16.0): [PMID:35972998] [10.1021/acs.jmedchem.2c00911]

Source